Hot Features
プレミアム
Arbutus Biopharma Corporation (ABUS)
NASDAQ
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid na... Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. 詳細を表示
Believes Now Is the Logical Time for Arbutus to Pursue a License and Collaboration Agreement With a Strategic Partner and Explore All Options for HBV Portfolio Urges Arbutus to Commit to No...
WARMINSTER, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
50% of patients who had baseline HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial Overall, in Cohort A1, 25% of patients achieved...
WARMINSTER, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Imdusiran data from IM-PROVE I and IM-PROVE II Phase 2a clinical trials to be presented at upcoming AASLD - The Liver Meeting 2024 Multiple-ascending doses of AB-101 in healthy subjects in the...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.025 | -0.724637681159 | 3.45 | 3.52 | 3.365 | 558686 | 3.44874083 | CS |
| 4 | -0.435 | -11.2694300518 | 3.86 | 3.96 | 3.365 | 942397 | 3.60106089 | CS |
| 12 | -1.1013 | -24.3311313877 | 4.5263 | 4.61 | 3.365 | 1041576 | 3.9313697 | CS |
| 26 | 0.065 | 1.93452380952 | 3.36 | 4.725 | 2.915 | 1045127 | 3.7611022 | CS |
| 52 | 1.415 | 70.3980099502 | 2.01 | 4.725 | 1.98 | 1059103 | 3.25921645 | CS |
| 156 | -0.625 | -15.4320987654 | 4.05 | 4.725 | 1.69 | 1230586 | 3.04423958 | CS |
| 260 | 1.845 | 116.772151899 | 1.58 | 9 | 0.88 | 2132477 | 3.71451678 | CS |
db7
3週前
db7
3週前
mick
1月前
db7
2月前
mick
2月前
mick
3月前
db7
3月前
db7
3月前
db7
3月前
Monksdream
3月前
DewDiligence
4月前
Rockurstocks
4月前
Monksdream
4月前
mick
5月前
Monksdream
5月前
db7
5月前
db7
6月前
db7
6月前
db7
6月前
mick
6月前
db7
6月前
db7
6月前
db7
7月前
db7
7月前
MWM
7月前
db7
7月前
db7
7月前
Monksdream
7月前
mick
7月前
Monksdream
8月前
db7
8月前
mick
8月前
mick
8月前
mick
8月前
mick
8月前
mick
8月前
mick
8月前
Paullee
8月前
MWM
8月前
db7
8月前
MWM
8月前
db7
8月前
db7
9月前
Desert dweller
9月前
Desert dweller
10月前
MWM
10月前
Desert dweller
10月前
MWM
10月前
db7
10月前
MWM
10月前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
